Detalhe da pesquisa
1.
Sorafenib plus triplet therapy with venetoclax, azacitidine and homoharringtonine for refractory/relapsed acute myeloid leukemia with FLT3-ITD: A multicenter phase 2 study.
J Intern Med
; 295(2): 216-228, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37899297
2.
Decreasing circ_0014614 promotes the differentiation of bone marrow flineage cells into megakaryocytes in essential thrombocythemia via activiation of miR-138-5p/caspase3 axis.
Blood Cells Mol Dis
; 107: 102855, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38703475
3.
Genetic characteristics predict response to venetoclax plus hypomethylating agents in relapsed or refractory acute myeloid leukemia.
J Intern Med
; 293(3): 329-339, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36284445
4.
Concomitant targeting of FLT3 and BTK overcomes FLT3 inhibitor resistance in acute myeloid leukemia through the inhibition of autophagy.
Haematologica
; 108(6): 1500-1514, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36226489
5.
Hypomethylating agents plus modified priming regimens compared with venetoclax-based regimens based on molecular characteristics for newly diagnosed patients with acute myeloid leukemia: a multi-center cohort study.
Ann Hematol
; 102(12): 3369-3381, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37723307
6.
A phase 2 study of sorafenib combined with conventional therapies in refractory central nervous system leukemia.
Cancer
; 128(11): 2138-2147, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35315510
7.
Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation.
J Transl Med
; 20(1): 300, 2022 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35794565
8.
Cidofovir, a choice for salvage treatment of cytomegalovirus infection in patients with haploidentical hematopoietic stem cell transplantation.
Transpl Infect Dis
; 24(2): e13776, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34941004
9.
Inhibition of EZH2 by chidamide exerts antileukemia activity and increases chemosensitivity through Smo/Gli-1 pathway in acute myeloid leukemia.
J Transl Med
; 19(1): 117, 2021 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33743723
10.
Differential expression of circular RNAs in bone marrow-derived exosomes from essential thrombocythemia patients.
Cell Biol Int
; 45(4): 869-881, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33325145
11.
Low serum miR-223 expression predicts poor outcome in patients with acute myeloid leukemia.
J Clin Lab Anal
; 34(3): e23096, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31691380
12.
Higher EZH2 expression is associated with extramedullary infiltration in acute myeloid leukemia.
Tumour Biol
; 37(8): 11409-20, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27000755
13.
Clinical and genetic characteristics predict outcomes of acute myeloid leukemia patients with FLT3 mutations receiving venetoclax-based therapy.
Cancer Med
; 13(2): e6885, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38334500
14.
Impact of measurable residual disease in combination with CD19 on postremission therapy choices for adult t(8;21) acute myeloid leukemia in first complete remission.
Cancer Med
; 13(4): e7074, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38457215
15.
Overexpression of amyloid precursor protein in acute myeloid leukemia enhances extramedullary infiltration by MMP-2.
Tumour Biol
; 34(2): 629-36, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23179400
16.
Allo-HSCT for acute leukemia of ambiguous lineage in adults: the comparison between standard conditioning and intensified conditioning regimens.
Ann Hematol
; 92(5): 679-87, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23274355
17.
The multi-kinase inhibitor CG-806 exerts anti-cancer activity against acute myeloid leukemia by co-targeting FLT3, BTK, and Aurora kinases.
Res Sq
; 2023 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36865133
18.
Identifying prognostic biomarker related to immune infiltration in acute myeloid leukemia.
Clin Exp Med
; 23(8): 4553-4562, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37561221
19.
Venetoclax Combined with Azacitidine and Homoharringtonine in Relapsed/Refractory AML: A Multicenter, Phase 2 Trial.
J Hematol Oncol
; 16(1): 42, 2023 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37120593
20.
Changing epidemiology, microbiology and mortality of bloodstream infections in patients with haematological malignancies before and during SARS-CoV-2 pandemic: a retrospective cohort study.
BMJ Open
; 13(12): e078510, 2023 12 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38159939